{"id":"NCT02308007","sponsor":"Curatek Pharmaceuticals, LLC","briefTitle":"Multi-Center Study of New Medications to Treat Vaginal Infections","officialTitle":"Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-06","primaryCompletion":"2018-06","completion":"2018-06","firstPosted":"2014-12-04","resultsPosted":"2020-08-04","lastUpdate":"2020-08-04"},"enrollment":475,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Vaginal Infection"],"interventions":[{"type":"DRUG","name":"Terconazole","otherNames":[]},{"type":"DRUG","name":"Metronidazole","otherNames":[]},{"type":"DRUG","name":"Terconazole/metronidazole","otherNames":[]}],"arms":[{"label":"Terconazole vaginal gel","type":"ACTIVE_COMPARATOR"},{"label":"Metronidazole vaginal gel","type":"ACTIVE_COMPARATOR"},{"label":"Terconazole/metronidazole vaginal gel","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the safety and efficacy of terconazole/metronidazole gel in the treatment of vaginal infections","primaryOutcome":{"measure":"Clinical Cure of Mixed Infection (BV and VVC) as Assessed by the Investigator at the Test-of-cure Visit","timeFrame":"7-14 days after beginning treatment","effectByArm":[{"arm":"Terconazole Vaginal Gel","deltaMin":31,"sd":null},{"arm":"Metronidazole Vaginal Gel","deltaMin":29,"sd":null},{"arm":"Terconazole/Metronidazole Vaginal Gel","deltaMin":43,"sd":null}],"pValues":[{"comp":"OG001 vs OG002","p":"0.030"},{"comp":"OG000 vs OG002","p":"0.073"},{"comp":"OG001 vs OG002","p":"0.0204"},{"comp":"OG000 vs OG002","p":"0.0493"}]},"eligibility":{"minAge":"12 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":51,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":149},"commonTop":["Vulvovaginal burning sensation"]}}